Effects of Curcumin on Postprandial Blood Glucose, and Insulin in Healthy Subjects

This study has been completed.

Sponsor:

Information provided by:

Skane University Hospital

ClinicalTrials.gov Identifier:

NCT01029327

First received: December 8, 2009

Last updated: NA

Last verified: June 2009

History: No changes posted

Tracking Information
First Received Date ^ICMJE	December 8, 2009
Last Updated Date	December 8, 2009
Start Date ^ICMJE	June 2009
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	No Changes Posted
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Effects of Curcumin on Postprandial Blood Glucose, and Insulin in Healthy Subjects
Official Title ^ICMJE	Not Provided
Brief Summary	Previous animal studies have shown that extracts of Curcumin lowers blood glucose.
Detailed Description	To study the effect of curcumin on postprandial blood glucose and plasma concentrations of insulin in fifteen healthy subjects.
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Case-Crossover Time Perspective: Cross-Sectional
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Healthy subjects recruited from the population in southern Sweden.
Condition ^ICMJE	Diabetes
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Healthy subjects
Publications *	Wickenberg J, Ingemansson SL, Hlebowicz J. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Nutr J. 2010 Oct 12;9:43.
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	Not Provided
Completion Date	September 2009
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: Fifteen healthy subjects without symptoms or a history of gastrointestinal disease, abdominal surgery or diabetes mellitus, were included in this crossover study. Exclusion Criteria: Connective tissue disease or cerebrovascular or endocrine disease.
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	Yes
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Sweden

Administrative Information
NCT Number ^ICMJE	NCT01029327
Other Study ID Numbers ^ICMJE	353/2008c
Has Data Monitoring Committee	Yes
Responsible Party	Not Provided
Study Sponsor ^ICMJE	Skane University Hospital
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Skane University Hospital
Verification Date	June 2009
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top